Urine | Feces | Blood | Brain | Liver | Digestive tract | Kidney | Ovaries/testes | Fat | Carcass | Muscle | Cage | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group A | |||||||||||||
M n = 3 | |||||||||||||
ppb | 0.15 ± 0.02 | 0.10 ± 0.02 | 0.22 ± 0.04 | 0.73 ± 0.29 | 0.20 ± 0.05 | 0.12 ± 0.02 | 0.09 ± 0.02 | 0.11 ± 0.02 | 0.12 ± 0.01 | ||||
% | 57.5 ± 4.8 | 13.7 ± 2.5 | 0.17 | 0.02 | 0.31 | 2.15 | 0.04 | 0.05 | 0.08 | 2.65 | 0.02 | 1.52 | 78.1 |
F n = 3 | |||||||||||||
ppb | 0.14 ± 0.02 | 0.08 ± 0.01 | 0.17 ± 0.03 | 0.58 ± 0.21 | 0.16 ± 0.03 | 0.12 ± 0.03 | 0.09 ± 0.01 | 0.12 ± 0.05 | 0.12 ± 0.05 | ||||
% | 40.0 ± 4.9 | 22.5 ± 3.6 | 0.13 | 0.02 | 0.21 | 1.44 | 0.04 | 0.02 | 0.06 | 2.87 | 0.01 | 0.96 | 68.2 |
Group B | |||||||||||||
M n = 3 | |||||||||||||
ppb | 1128 ± 55 | 667 ± 25 | 1743 ± 24 | 7944 ± 2485 | 1385 ± 136 | 1118 ± 100 | 481 ± 27 | 746 ± 67 | 889 ± 19 | ||||
% | 56.9 ± 9.0 | 16.7 ± 3.6 | 0.16 | 0.02 | 0.25 | 1.99 | 0.03 | 0.04 | 0.02 | 1.81 | 0.01 | 1.04 | 78.9 |
F n = 3 | |||||||||||||
ppb | 1311 ± 235 | 621 ± 45 | 1729 ± 143 | 10422 ± 4023 | 1456 ± 152 | 869 ± 67 | 546 ± 72 | 990 ± 136 | 795 ± 40 | ||||
% | 40.8 ± 3.9 | 21.0 ± 3.0 | 0.15 | 0.02 | 0.20 | 2.93 | 0.03 | 0.01 | 0.03 | 2.31 | 0.01 | 1.15 | 68.6 |
Residual levels of radioactivity measured in excreta and tissues of male and female Wistar rats dosed orally with 1 μg/kg (group A) or 10 mg/kg (group B) 3H-labeled 4-n-NP. Results are expressed as nanograms of NP Eq per gram wet weight (ppb) and in percent of the total radioactivity administered to animals over the 4-day study. M, males; F, females.